[Federal Register Volume 87, Number 176 (Tuesday, September 13, 2022)]
[Notices]
[Pages 56103-56107]
[FR Doc No: 2022-19683]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-95694; File No. SR-NYSEAMER-2022-39]

Self-Regulatory Organizations; NYSE American LLC; Notice of
Filing and Immediate Effectiveness of a Proposed Rule Change To Modify
the NYSE American Options Fee Schedule

September 7, 2022.
    Pursuant to Section 19(b)(1) \1\ of the Securities Exchange Act of
1934 (``Act'') \2\ and Rule 19b-4 thereunder,\3\ notice is hereby given
that, on August 31, 2022, NYSE American LLC (``NYSE American'' or the
``Exchange'') filed with the Securities and Exchange Commission (the
``Commission'') the proposed rule change as described in Items I, II,
and III below, which Items have been prepared by the self-regulatory
organization. The Commission is publishing this notice to solicit
comments on the proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 15 U.S.C. 78a.
    \3\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange proposes to modify the NYSE American Options Fee
Schedule (``Fee Schedule'') regarding credits for certain Qualified
Contingent Cross (``QCC'') transactions and to make an administrative
change. The Exchange proposes to implement the fee change effective
September 1, 2022. The proposed rule change is available on the
Exchange's website at www.nyse.com, at the principal office of the
Exchange, and at the Commission's Public Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the self-regulatory organization
included statements concerning the purpose of, and basis for, the
proposed rule change and discussed any comments it received on the
proposed rule change. The text of those statements may be examined at
the places specified in Item IV below. The Exchange has prepared
summaries, set forth in sections A, B, and C below, of the most
significant parts of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and the
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The purpose of this filing to amend the Fee Schedule to (1) modify
Floor Broker credits for QCC transactions,\4\ and (2) make an
administrative change to the table setting forth fees for Premium
Products to reflect a ticker symbol change. The Exchange proposes to
implement the rule change on September 1, 2022.
---------------------------------------------------------------------------

    \4\ A QCC is comprised of an originating order to buy or sell at
least 1,000 contracts, or 10,000 mini-options contracts, that is
identified as being part of a qualified contingent trade (as such
term is defined in Commentary .01 to Rule 900.3NY), coupled with a
contra side order or orders totaling an equal number of contracts.
See Rule 900.3NY(y).
---------------------------------------------------------------------------

Floor Broker QCC Credits
    The Exchange proposes to modify the credits available to Floor
Brokers on QCC orders. Currently, Floor Brokers earn a credit for
executed QCC orders of ($0.07) per contract for the first 300,000
contracts or ($0.10) per contract in excess of 300,000.\5\ The Exchange
currently limits the maximum Floor Broker credit to $525,000 per month
per Floor Broker firm.\6\ QCC executions in which a Customer or
Professional Customer, or both, is on both sides of the QCC trade are
not eligible for the Floor Broker credit, and the Floor Broker credit
is paid only on volume within the applicable tier and is not
retroactive to the first contract traded.\7\
---------------------------------------------------------------------------

    \5\ See Fee Schedule, Section I.F., QCC Fees & Credits,
available here, https://www.nyse.com/publicdocs/nyse/markets/american-options/NYSE_American_Options_Fee_Schedule.pdf. See id.,
Section I.F., Footnote 1.
    \6\ See id., Section I.F. Footnote 1.
    \7\ See id.
---------------------------------------------------------------------------

    The Exchange now proposes to increase the amount of the credits
available to Floor Brokers for executed QCC orders. Specifically, the
Exchange proposes that Floor Brokers may earn a credit of ($0.08) per
contract for the first 300,000 contracts and a credit of ($0.11) per
contract on all contracts above 300,000 in a month.
    Although the Exchange cannot predict with certainty whether the
proposed change would encourage Floor Brokers to increase their QCC
volume, the proposed change is intended to continue to incent
additional QCC executions by Floor Brokers by increasing the credits
available on such orders, and all Floor Brokers are eligible to qualify
for the proposed credits.
Ticker Symbol Change
    The Exchange proposes to make an administrative change to Section
III.D. of the Fee Schedule to reflect a ticker symbol change. Section
III.D., NYSE American Options Market Maker Monthly Premium Product Fee,
sets forth the monthly fee assessed to NYSE American Options Market
Makers that transact in certain Premium Products set forth in a table
(the ``Premium Products Table'') in this section of the Fee Schedule.
One such product, Meta Platforms, Inc., changed its trading symbol from
FB to META effective June 9, 2022. Accordingly, the Exchange proposes
to update the Premium Products Table to replace ``FB'' with ``META.''
The Exchange believes this proposed change would improve the clarity
and accuracy of the Fee Schedule by ensuring that the Premium Products
Table reflects the current ticker symbol for all Premium Products.
2. Statutory Basis
    The Exchange believes that the proposed rule change is consistent
with Section 6(b) of the Act,\8\ in general, and furthers the
objectives of Sections 6(b)(4) and (5) of the Act,\9\ in particular,
because it provides for the equitable allocation of reasonable dues,
fees, and other charges among its members, issuers and other persons
using its facilities and does not unfairly discriminate between
customers, issuers, brokers or dealers.
---------------------------------------------------------------------------

    \8\ 15 U.S.C. 78f(b).
    \9\ 15 U.S.C. 78f(b)(4) and (5).
---------------------------------------------------------------------------

The Proposed Rule Change is Reasonable
    The Exchange operates in a highly competitive market. The
Commission has repeatedly expressed its preference for competition over
regulatory intervention in determining prices, products, and services
in the securities markets. In Regulation NMS, the Commission
highlighted the importance of market forces in determining prices and
SRO revenues and, also, recognized that current regulation of the
market system ``has been remarkably successful in promoting market
competition in its broader forms that are most important to investors
and listed companies.'' \10\
---------------------------------------------------------------------------

    \10\ See Securities Exchange Act Release No. 51808 (June 9,
2005), 70 FR 37496, 37499 (June 29, 2005) (S7-10-04) (``Reg NMS
Adopting Release'').
---------------------------------------------------------------------------

    There are currently 16 registered options exchanges competing for
order flow. Based on publicly-available information, and excluding
index-based options, no single exchange has more than 16% of the market
share of executed volume of multiply-listed equity and ETF options
trades.\11\ Therefore, no exchange possesses significant pricing power
in the execution of multiply-listed equity and ETF options order flow.
More specifically, in July 2022, the Exchange had less than 8% market
share of executed volume of multiply-listed equity and ETF options
trades.\12\
---------------------------------------------------------------------------

    \11\ The OCC publishes options and futures volume in a variety
of formats, including daily and monthly volume by exchange,
available here: https://www.theocc.com/Market-Data/Market-Data-Reports/Volume-and-Open-Interest/Monthly-Weekly-Volume-Statistics.
    \12\ Based on a compilation of OCC data for monthly volume of
equity-based options and monthly volume of ETF-based options, see
id., the Exchange's market share in equity-based options was 7.53%
for the month of July 2021 and 7.26% for the month of July 2022.
---------------------------------------------------------------------------

    The Exchange believes that the ever-shifting market share among the
exchanges from month to month demonstrates that market participants can
shift order flow, or discontinue or reduce use of certain categories of
products, in response to fee changes. Accordingly, competitive forces
constrain options exchange transaction fees. Stated otherwise, changes
to exchange transaction fees can have a direct effect on the ability of
an exchange to compete for order flow.
    To respond to this competitive marketplace, the Exchange has
established incentives to assist Floor Brokers in attracting more
business to the Exchange--including credits on QCC transactions--as
such participants serve an important function in facilitating the
execution of orders on the Exchange (including via open outcry),
thereby promoting price discovery on the public markets.
    The Exchange believes that the proposed modification of the credits
offered to Floor Brokers on QCC transactions is reasonable because it
is designed to continue to incent Floor Brokers to increase the number
of QCC transactions sent to the Exchange. To the extent that the
proposed change attracts more volume to the Exchange, this increased
order flow would continue to make the Exchange a more competitive venue
for order execution, which, in turn, promotes just and equitable
principles of trade and removes impediments to and perfects the
mechanism of a free and open market and a national market system. The
Exchange notes that all market participants stand to benefit from any
increase in volume by Floor Brokers, which could promote market depth,
facilitate tighter spreads and enhance price discovery to the extent
the proposed change encourages Floor Brokers to utilize the Exchange as
a primary trading venue, and may lead to a corresponding increase in
order flow from other market participants. In

addition, any increased liquidity on the Exchange would result in
enhanced market quality for all participants.
    Finally, to the extent the proposed change continues to attract
greater volume and liquidity, the Exchange believes the proposed change
would improve the Exchange's overall competitiveness and strengthen its
market quality for all market participants. In the backdrop of the
competitive environment in which the Exchange operates, the proposed
rule change is a reasonable attempt by the Exchange to increase the
depth of its market and improve its market share relative to its
competitors. The Exchange's fees are constrained by intermarket
competition, as Floor Brokers may direct their order flow to any of the
16 options exchanges, including those offering rebates on QCC
orders.\13\ Thus, Floor Brokers have a choice of where they direct
their order flow, including their QCC transactions. The proposed rule
change is designed to continue to incent Floor Brokers to direct
liquidity to the Exchange and, in particular, QCC orders, thereby
promoting market depth, price discovery and improvement, and enhanced
order execution opportunities for market participants, particularly to
the extent Floor Brokers are incentivized to aggregate their trading
activity at the Exchange.
---------------------------------------------------------------------------

    \13\ See, e.g., EDGX Options Exchange Fee Schedule, QCC
Initiator/Solicitation Rebate Tiers (applying ($0.22) per contract
rebate up to 999,999 contracts for QCC transactions with non-
customers on both sides); BOX Options Fee Schedule at Section
IV.D.1. (QCC Rebate) (providing for ($0.22) per contract rebate up
to 1,499,999 contracts for QCC transactions when both parties are a
broker-dealer or market maker); Nasdaq ISE, Options 7, Section 6.A.
(QCC and Solicitation Rebate) (offering rebates on QCC transactions
of up to ($0.11) on 1,000,000 or more contract sides in a month).
---------------------------------------------------------------------------

    The Exchange believes that the proposed administrative change with
respect to the Premium Products Table is reasonable because it would
update the table to reflect the current ticker symbols for all Premium
Products, thereby ensuring that the Fee Schedule clearly and accurately
sets forth the products subject to the fees in Section III.D.
The Proposed Rule Change Is an Equitable Allocation of Credits and Fees
    The Exchange believes the proposed rule change is an equitable
allocation of its fees and credits. The proposed modification of QCC
credits is based on the amount and type of business transacted on the
Exchange, and Floor Brokers can attempt to trade QCC orders to earn the
increased credits or not. In addition, the proposed credits are
available to all Floor Brokers equally. The Exchange also believes that
the proposed credits are an equitable allocation of fees and credits
because they would encourage and support Floor Brokers' role in
facilitating the execution of orders on the Exchange, and to the extent
the proposed credits incent Floor Brokers to direct increased liquidity
to the Exchange, all market participants would benefit from enhanced
opportunities for price improvement and order execution.
    Moreover, the proposed credits are designed to incent Floor Brokers
to encourage OTP Holders to aggregate their executions--particularly
QCC transactions--at the Exchange as a primary execution venue. To the
extent that the proposed changes attract more QCC volume to the
Exchange, this increased order flow would continue to make the Exchange
a more competitive venue for, among other things, order execution.
Thus, the Exchange believes the proposed rule change would improve
market quality for all market participants on the Exchange and, as a
consequence, attract more order flow to the Exchange, thereby improving
market-wide quality and price discovery.
    The Exchange also believes that the proposed change relating to the
Premium Products Table is equitable because it would ensure that the
table accurately reflects the ticker symbol for all Premium Products,
to the benefit of all OTP Holders.
The Proposed Rule Change Is Not Unfairly Discriminatory
    The Exchange believes it is not unfairly discriminatory to modify
the credits offered to Floor Brokers on QCC orders because the proposed
credits would be available to all similarly-situated Floor Brokers on
an equal and non-discriminatory basis. The proposed credits are also
not unfairly discriminatory to non-Floor Brokers because Floor Brokers
serve an important function in facilitating the execution of orders on
the Exchange (including via open outcry), which the Exchange wishes to
encourage and support to promote price improvement opportunities for
all market participants.
    The proposal is based on the amount and type of business transacted
on the Exchange, and Floor Brokers are not obligated to execute QCC
orders. Rather, the proposal is designed to encourage Floor Brokers to
utilize the Exchange as a primary trading venue for all transactions
(if they have not done so previously) and increase QCC volume sent to
the Exchange. To the extent that the proposed change attracts more QCC
orders to the Exchange, this increased order flow would continue to
make the Exchange a more competitive venue for order execution. Thus,
the Exchange believes the proposed rule change would improve market
quality for all market participants on the Exchange and, as a
consequence, attract more order flow to the Exchange, thereby improving
market-wide quality and price discovery. The resulting increased volume
and liquidity would provide more trading opportunities and tighter
spreads to all market participants and thus would promote just and
equitable principles of trade, remove impediments to and perfect the
mechanism of a free and open market and a national market system and,
in general, protect investors and the public interest.
    The Exchange also believes that the proposed change to modify the
Premium Products Table is not unfairly discriminatory because it is
designed to update the table to include the current ticker symbol for
all Premium Products, to the benefit of all OTP Holders.
    Finally, the Exchange believes that it is subject to significant
competitive forces, as described below in the Exchange's statement
regarding the burden on competition.

B. Self-Regulatory Organization's Statement on Burden on Competition

    In accordance with Section 6(b)(8) of the Act, the Exchange does
not believe that the proposed rule change would impose any burden on
competition that is not necessary or appropriate in furtherance of the
purposes of the Act. Instead, as discussed above, the Exchange believes
that the proposed changes would encourage the submission of additional
liquidity to a public exchange, thereby promoting market depth, price
discovery and transparency and enhancing order execution opportunities
for all market participants. As a result, the Exchange believes that
the proposed change furthers the Commission's goal in adopting
Regulation NMS of fostering integrated competition among orders, which
promotes ``more efficient pricing of individual stocks for all types of
orders, large and small.'' \14\
---------------------------------------------------------------------------

    \14\ See Reg NMS Adopting Release, supra note 10, at 37499.
---------------------------------------------------------------------------

    Intramarket Competition. The proposed increased credits are
designed to attract additional order flow to the Exchange (particularly
in Floor Brokers' QCC transactions), which could increase the volumes
of contracts traded on the Exchange. Greater liquidity benefits all

market participants on the Exchange, and increased QCC transactions
would increase opportunities for execution of other trading interest.
The proposed credits would be available to all similarly-situated Floor
Brokers that execute QCC trades, and to the extent that there is an
additional competitive burden on non-Floor Brokers, the Exchange
believes that any such burden would be appropriate because Floor
Brokers serve an important function in facilitating the execution of
orders (including via open outcry) and price discovery for all market
participants.
    The Exchange does not believe that the proposed change relating to
the Premium Products Table would impose any burden on intramarket
competition, as it is merely intended to improve the clarity of the Fee
Schedule by ensuring that the table reflects all Premium Products'
current ticker symbols.
    Intermarket Competition. The Exchange operates in a highly
competitive market in which market participants can readily favor one
of the 16 competing option exchanges if they deem fee levels at a
particular venue to be excessive. In such an environment, the Exchange
must continually adjust its fees to remain competitive with other
exchanges and to attract order flow to the Exchange. Based on publicly-
available information, and excluding index-based options, no single
exchange has more than 16% of the market share of executed volume of
multiply-listed equity and ETF options trades.\15\ Therefore, no
exchange possesses significant pricing power in the execution of
multiply-listed equity and ETF options order flow. More specifically,
in July 2022, the Exchange had less than 8% market share of executed
volume of multiply-listed equity and ETF options trades.\16\
---------------------------------------------------------------------------

    \15\ See note 11, supra.
    \16\ See note 12, supra.
---------------------------------------------------------------------------

    The Exchange believes that the proposed rule change reflects this
competitive environment because it modifies the Exchange's fees in a
manner designed to incent Floor Brokers to direct trading interest
(particularly QCC transactions) to the Exchange, to provide liquidity
and to attract order flow. To the extent that Floor Brokers are
incentivized to utilize the Exchange as a primary trading venue for all
transactions, all of the Exchange's market participants should benefit
from the improved market quality and increased opportunities for price
improvement.
    The Exchange notes that it operates in a highly competitive market
in which market participants can readily favor competing venues. In
such an environment, the Exchange must continually review, and consider
adjusting, its fees and credits to remain competitive with other
exchanges. For the reasons described above, the Exchange believes that
the proposed rule change reflects this competitive environment. The
Exchange further believes that the proposed change could promote
competition between the Exchange and other execution venues, including
those that currently offer rebates on QCC transactions, by encouraging
additional orders (and, in particular, QCC orders) to be sent to the
Exchange for execution.\17\
---------------------------------------------------------------------------

    \17\ See note 13, supra.
---------------------------------------------------------------------------

    The Exchange does not believe that the proposed change to update
the Premium Products Table would impact intermarket competition because
the proposed modification of the table is intended only to ensure that
it reflects the accurate ticker symbol for all Premium Products,
thereby improving the clarity and accuracy of the Fee Schedule,
reducing burdens on the marketplace, and facilitating investor
protection.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    No written comments were solicited or received with respect to the
proposed rule change.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    The foregoing rule change is effective upon filing pursuant to
Section 19(b)(3)(A) \18\ of the Act and subparagraph (f)(2) of Rule
19b-4 \19\ thereunder, because it establishes a due, fee, or other
charge imposed by the Exchange.
---------------------------------------------------------------------------

    \18\ 15 U.S.C. 78s(b)(3)(A).
    \19\ 17 CFR 240.19b-4(f)(2).
---------------------------------------------------------------------------

    At any time within 60 days of the filing of such proposed rule
change, the Commission summarily may temporarily suspend such rule
change if it appears to the Commission that such action is necessary or
appropriate in the public interest, for the protection of investors, or
otherwise in furtherance of the purposes of the Act. If the Commission
takes such action, the Commission shall institute proceedings under
Section 19(b)(2)(B) \20\ of the Act to determine whether the proposed
rule change should be approved or disapproved.
---------------------------------------------------------------------------

    \20\ 15 U.S.C. 78s(b)(2)(B).
---------------------------------------------------------------------------

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's internet comment form (http://www.sec.gov/rules/sro.shtml); or
     Send an email to [email protected]. Please include
File Number SR-NYSEAMER-2022-39 on the subject line.

Paper Comments

     Send paper comments in triplicate to Secretary, Securities
and Exchange Commission, 100 F Street NE, Washington, DC 20549-1090.

All submissions should refer to File Number SR-NYSEAMER-2022-39. This
file number should be included on the subject line if email is used. To
help the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's internet website (http://www.sec.gov/rules/sro.shtml).
Copies of the submission, all subsequent amendments, all written
statements with respect to the proposed rule change that are filed with
the Commission, and all written communications relating to the proposed
rule change between the Commission and any person, other than those
that may be withheld from the public in accordance with the provisions
of 5 U.S.C. 552, will be available for website viewing and printing in
the Commission's Public Reference Room, 100 F Street NE, Washington, DC
20549 on official business days between the hours of 10:00 a.m. and
3:00 p.m. Copies of the filing also will be available for inspection
and copying at the principal office of the Exchange. All comments
received will be posted without change. Persons submitting comments are
cautioned that we do not redact or edit personal identifying
information from comment submissions. You should submit only
information that you wish to make available publicly. All submissions
should refer to File Number SR-NYSEAMER-2022-39, and should be
submitted on or before October 4, 2022.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\21\
---------------------------------------------------------------------------

    \21\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

J. Matthew DeLesDernier,
Deputy Secretary.
[FR Doc. 2022-19683 Filed 9-12-22; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 81, Number 52 (Thursday, March 17, 2016)]
[Notices]
[Pages 14438-14439]
[FR Doc No: 2016-06021]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings #1

    Take notice that the Commission received the following electric
corporate filings:

    Docket Numbers: EC11-35-000.
    Applicants: NSTAR, Northeast Utilities.
    Description: Informational Filing of Eversource Energy Service
Company.
    Filed Date: 2/29/16.
    Accession Number: 20160229-5193.
    Comments Due: 5 p.m. ET 3/22/16.

    Docket Numbers: EC16-83-000.
    Applicants: High Lonesome Mesa Wind Holdings, LLC, High Lonesome
Holdings, LLC.
    Description: Amendment to February 29, 2016 Application for
Authorization under Section 203 of the Federal Power Act of High
Lonesome Holdings, LLC, et al.
    Filed Date: 3/10/16.
    Accession Number: 20160310-5212.
    Comments Due: 5 p.m. ET 3/21/16.

    Take notice that the Commission received the following exempt
wholesale generator filings:

    Docket Numbers: EG16-69-000.
    Applicants: Roswell Solar, LLC.
    Description: Notice of Self-Certification of Exempt Wholesale
Generator Status of Roswell Solar, LLC.
    Filed Date: 3/11/16.
    Accession Number: 20160311-5047.
    Comments Due: 5 p.m. ET 4/1/16.

    Docket Numbers: EG16-70-000.
    Applicants: Chaves County Solar, LLC.
    Description: Notice of Self-Certification of Exempt Wholesale
Generator Status of Chaves County Solar, LLC.
    Filed Date: 3/11/16.
    Accession Number: 20160311-5050.
    Comments Due: 5 p.m. ET 4/1/16.

    Take notice that the Commission received the following electric
rate filings:.

    Docket Numbers: ER13-96-008.
    Applicants: Black Hills Power, Inc.
    Description: Compliance filing: Compliance Filing to Correct
eTariff Record to be effective 10/1/2015.
    Filed Date: 3/10/16.
    Accession Number: 20160310-5184.
    Comments Due: 5 p.m. ET 3/31/16.

    Docket Numbers: ER13-97-008.
    Applicants: Black Hills/Colorado Electric Utility Co.
    Description: Compliance filing: Compliance Filing to Correct
eTariff Record to be effective 10/1/2015.
    Filed Date: 3/10/16.
    Accession Number: 20160310-5185.
    Comments Due: 5 p.m. ET 3/31/16.

    Docket Numbers: ER13-120-008.
    Applicants: Cheyenne Light, Fuel and Power Company.
    Description: Compliance filing: Compliance Filing to Correct
eTariff Record to be effective 10/1/2015.
    Filed Date: 3/10/16.
    Accession Number: 20160310-5186.
    Comments Due: 5 p.m. ET 3/31/16.

    Docket Numbers: ER15-1218-002; ER15-2224-001.
    Applicants: Solar Star California XIII, LLC, Solar Star Colorado
III, LLC.
    Description: Notice of Non-Material Change in Status of Solar Star
California XIII, LLC and Solar Star Colorado III, LLC.
    Filed Date: 3/10/16.
    Accession Number: 20160310-5206.
    Comments Due: 5 p.m. ET 3/31/16.

    Docket Numbers: ER16-168-002.
    Applicants: New York Independent System Operator, Inc.
    Description: Compliance filing: NYISO compliance re: unauthorized
natural gas use to be effective 2/18/2016.
    Filed Date: 3/11/16.
    Accession Number: 20160311-5051.
    Comments Due: 5 p.m. ET 4/1/16.

    Docket Numbers: ER16-532-001.
    Applicants: PJM Interconnection, L.L.C.
    Description: Compliance filing: Compliance Filing per 2/12/16 Order
in Docket No. ER16-532 to be effective 2/15/2016.
    Filed Date: 3/11/16.
    Accession Number: 20160311-5197.
    Comments Due: 5 p.m. ET 4/1/16.

    Docket Numbers: ER16-917-001; ER14-2458-001; ER11-3013-005; ER10-
2872-005; ER10-2870-006; ER10-2868-005; ER10-2865-006; ER10-2860-007.

    Applicants: TC Ironwood LLC, TransCanada Power Marketing Ltd,
TransCanada Energy Sales Ltd., TC Ravenswood, LLC, TransCanada Maine
Wind Development Inc., TransCanada Hydro Northeast Inc., Ocean State
Power LLC, Coolidge Power LLC.
    Description: Amendment to March 2, 2016 Notice of Non-Material
Change in Status of TransCanada MBR Sellers.
    Filed Date: 3/8/16.
    Accession Number: 20160308-5148.
    Comments Due: 5 p.m. ET 3/18/16.

    Docket Numbers: ER16-1135-000.
    Applicants: Healthy Planet Partners Energy Company, LLC.
    Description: Tariff Cancellation: MBRA Amendment Cancellation to be
effective 3/31/2016.
    Filed Date: 3/11/16.
    Accession Number: 20160311-5007.
    Comments Due: 5 p.m. ET 4/1/16.

    Docket Numbers: ER16-1136-000.
    Applicants: Southwest Power Pool, Inc.
    Description: Sec.  205(d) Rate Filing: 1154R12 Associated Electric
Cooperative NITSA and NOA to be effective 3/1/2016.
    Filed Date: 3/11/16.
    Accession Number: 20160311-5049.
    Comments Due: 5 p.m. ET 4/1/16.

    Docket Numbers: ER16-1138-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Request of PJM Interconnection, L.L.C. for Limited
Tariff Waiver and Expedited Treatment.
    Filed Date: 3/11/16.
    Accession Number: 20160311-5083.
    Comments Due: 5 p.m. ET 03/21/16.

    Docket Numbers: ER16-1142-000.
    Applicants: Innovative Solar 43, LLC.
    Description: Tariff Cancellation: Innovative Solar 43, LLC Notice
of Cancellation to be effective 3/12/2016.
    Filed Date: 3/11/16.

    Accession Number: 20160311-5148.
    Comments Due: 5 p.m. ET 4/1/16.

    Docket Numbers: ER16-1143-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Tariff Cancellation: Notice of Cancellation of Beech
Ridge II ISA No. 3087, Queue No. M24 to be effective 5/2/2016.
    Filed Date: 3/11/16.
    Accession Number: 20160311-5157.
    Comments Due: 5 p.m. ET 4/1/16.

    Docket Numbers: ER16-1144-000.
    Applicants: PacifiCorp.
    Description: Tariff Cancellation: Termination of PAC Energy
Construction Agmt--Paisley to be effective 5/11/2016.
    Filed Date: 3/11/16.
    Accession Number: 20160311-5165.
    Comments Due: 5 p.m. ET 4/1/16.

    Docket Numbers: ER16-1145-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: First Revised Service
Agreement No. 4173; Queue Position Z1-066 to be effective 2/10/2016.
    Filed Date: 3/11/16.
    Accession Number: 20160311-5182.
    Comments Due: 5 p.m. ET 4/1/16.

    Take notice that the Commission received the following electric
securities filings:

    Docket Numbers: ES16-24-000.
    Applicants: MidAmerican Energy Company.
    Description: Application of MidAmerican Energy Company pursuant to
Section 204 of the Federal Power Act.
    Filed Date: 3/11/16.
    Accession Number: 20160311-5039.
    Comments Due: 5 p.m. ET 4/1/16.

    Docket Numbers: ER16-1146-000.
    Applicants: Union Power Partners, L.P.
    Description: Tariff Cancellation: Notice of Termination for Rate
Schedule FERC No. 2 to be effective 3/3/2016.
    Filed Date: 3/11/16.
    Accession Number: 20160311-5207.
    Comments Due: 5 p.m. ET 4/1/16.

    The filings are accessible in the Commission's eLibrary system by
clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: March 11, 2016.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2016-06021 Filed 3-16-16; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 88, Number 175 (Tuesday, September 12, 2023)]
[Notices]
[Pages 62562-62563]
[FR Doc No: 2023-19587]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ER23-2759-000]

Mammoth North LLC; Supplemental Notice That Initial Market-Based
Rate Filing Includes Request for Blanket Section 204 Authorization

    This is a supplemental notice in the above-referenced proceeding of
Mammoth North LLC's application for market-based rate authority, with
an accompanying rate tariff, noting that such application includes a
request for blanket authorization, under 18 CFR part 34, of future
issuances of securities and assumptions of liability.
    Any person desiring to intervene or to protest should file with the
Federal Energy Regulatory Commission, 888 First Street NE, Washington,
DC 20426,

in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211 and 385.214). Anyone filing a
motion to intervene or protest must serve a copy of that document on
the Applicant.
    Notice is hereby given that the deadline for filing protests with
regard to the applicant's request for blanket authorization, under 18
CFR part 34, of future issuances of securities and assumptions of
liability, is September 25, 2023.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov. To facilitate electronic service, persons with internet
access who will eFile a document and/or be listed as a contact for an
intervenor must create and validate an eRegistration account using the
eRegistration link. Select the eFiling link to log on and submit the
intervention or protests.
    Persons unable to file electronically may mail similar pleadings to
the Federal Energy Regulatory Commission, 888 First Street NE,
Washington, DC 20426. Hand delivered submissions in docketed
proceedings should be delivered to Health and Human Services, 12225
Wilkins Avenue, Rockville, Maryland 20852.
    In addition to publishing the full text of this document in the
Federal Register, the Commission provides all interested persons an
opportunity to view and/or print the contents of this document via the
internet through the Commission's Home Page (http://www.ferc.gov) using
the ``eLibrary'' link. Enter the docket number excluding the last three
digits in the docket number field to access the document. At this time,
the Commission has suspended access to the Commission's Public
Reference Room, due to the proclamation declaring a National Emergency
concerning the Novel Coronavirus Disease (COVID-19), issued by the
President on March 13, 2020. For assistance, contact the Federal Energy
Regulatory Commission at [email protected] or call toll-free,
(886) 208-3676 or TYY,<PHONE_NUMBER>.
    The Commission's Office of Public Participation (OPP) supports
meaningful public engagement and participation in Commission
proceedings. OPP can help members of the public, including landowners,
environmental justice communities, Tribal members and others, access
publicly available information and navigate Commission processes. For
public inquiries and assistance with making filings such as
interventions, comments, or requests for rehearing, the public is
encouraged to contact OPP at<PHONE_NUMBER> or [email protected].

    Dated: September 5, 2023.
Debbie-Anne A. Reese,
Deputy Secretary.
[FR Doc. 2023-19587 Filed 9-11-23; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 87, Number 72 (Thursday, April 14, 2022)]
[Notices]
[Pages 22212-22215]
[FR Doc No: 2022-08092]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2018-D-4533]

Compounding Animal Drugs From Bulk Drug Substances; Guidance for
Industry; Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of availability.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA, Agency, or we) is
announcing the availability of a final guidance for industry (GFI) #256
entitled ``Compounding Animal Drugs from Bulk Drug Substances.'' This
guidance describes FDA's current thinking about compounding animal
drugs from bulk drug substances, identifies our enforcement priorities
with respect to drugs compounded from bulk drug substances, and
describes circumstances under which FDA generally does not intend to
take action against veterinarians or pharmacists in either State-
licensed pharmacies or Federal facilities, who compound animal drugs
from bulk drug substances. We are also announcing that a proposed
collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995 (PRA).

DATES: The announcement of the guidance is published in the Federal
Register on April 14, 2022. Submit written comments (including
recommendations) on the collection of information by May 16, 2022.

ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be submitted to https://www.reginfo.gov/public/do/PRAMain. Find this particular information
collection by selecting ``Currently under Review--Open for Public
Comments'' or by using the search function. The OMB control number for
this information collection is 0910-NEW. Also include the FDA docket
number found in brackets in the heading of this document.
    You may submit either electronic or written comments on Agency
guidances at any time as follows:

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand Delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2018-D-4533 for ``Compounding Animal Drugs from Bulk Drug
Substances.'' Received comments will be placed in the docket and,
except for those submitted as ``Confidential Submissions,'' publicly
viewable at https://www.regulations.gov or at the Dockets Management
Staff between 9 a.m. and 4 p.m., Monday through Friday,<PHONE_NUMBER>.

     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852,<PHONE_NUMBER>.
    You may submit comments on any guidance at any time (see 21 CFR
10.115(g)(5)).
    Submit written requests for single copies of the guidance to the
Policy and Regulations Staff (HFV-6), Center for Veterinary Medicine,
Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855.
Send one self-addressed adhesive label to assist that office in
processing your requests. See the SUPPLEMENTARY INFORMATION section for
electronic access to the guidance document.

FOR FURTHER INFORMATION CONTACT: Cindy Burnsteel, Office of
Surveillance and Compliance (HFV-200), Food and Drug Administration,
7519 Standish Pl., Rockville, MD 20855,<PHONE_NUMBER>.
    Regarding the proposed collection of information: Domini Bean,
Office of Operations, Food and Drug Administration, Three White Flint
North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-
5733, [email protected].

SUPPLEMENTARY INFORMATION:

I. Background

    In the Federal Register of November 20, 2019 (84 FR 64085), FDA
published the notice of availability for draft GFI #256 entitled
``Compounding Animal Drugs from Bulk Drug Substances'' with a 90-day
comment period. In response to requests from interested parties, we
extended the comment period to July 17, 2020, and then to October 15,
2020. We requested comments on the draft guidance with respect to
animal drug compounding from bulk drug substances under certain
circumstances when no other medically appropriate treatment option
exists. This final GFI #256 describes FDA's current thinking about
compounding animal drugs from bulk drug substances, identifies our
enforcement priorities with respect to drugs compounded from bulk drug
substances, and describes circumstances under which FDA generally does
not intend to take action against veterinarians or pharmacists in
either State-licensed pharmacies or Federal facilities, who compound
animal drugs from bulk drug substances. FDA does not intend to take
action under sections 501(a)(2)(B) and (a)(5), 502(f), and 512(a) of
the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 351(a)(2)(B) and
(a)(5), 352(f), and 360(b)) under the circumstances described in GFI
#256.
    FDA received numerous comments on the draft guidance, which were
considered as the guidance was finalized. Changes made in response to
comments include identifying compliance with relevant State and local
laws as the standard for compounding methods and eliminating references
to United States Pharmacopeia and National Formulary Chapters <795>
``Pharmaceutical Compounding--Nonsterile Preparations'' and <797>
``Pharmaceutical Compounding--Sterile Preparations.'' We also revised
the recommended label statement regarding reporting of adverse events
to include reporting to the pharmacy as well as FDA.
    We also made a number of changes related to recommendations for
copies of approved products. We simplified the definition of ``copy''
used in the guidance and clarified that ``clinical difference''
includes issues affecting patient compliance and the safety of these
who administer the drug, but excludes cost differences between approved
and compounded products. The final guidance includes examples of how to
briefly describe the medical rationale for making a copy, such as the
compounding pharmacist contacting the prescribing veterinarian to
obtain the rationale and noting it in the compounding records as an
alternative to the veterinarian noting the rationale on the
prescription. It also provides examples of rationales to explain why an
approved drug cannot be used in a legal extralabel manner to compound a
drug with the same active moiety.
    We also made changes to lists of bulk drug substances for
compounding office stock for nonfood-producing animals or antidotes for
food-producing animals. As outlined in the Appendix to the final
guidance,\1\ we streamlined the nomination process for these bulk drug
substances, reducing the information requested by FDA to support a
nomination. The list of bulk substances to compound drugs for use in
food-producing animals has been expanded to encompass nominations of
sedatives or anesthetics for free-ranging wildlife species.
---------------------------------------------------------------------------

    \1\ Elsewhere in this issue of the Federal Register, FDA is
requesting nominations or renominations for bulk drug substances to
be included on the ``Lists of Bulk Drug Substances for Compounding
Office Stock Drugs for Use in Nonfood-Producing Animals or Drugs for
Use in Food-Producing Animals or Free-Ranging Wildlife Species'' for
inclusion on a list of bulk drug substances for compounding certain
animal drugs without a patient specific prescription (i.e., office
stock) for use in nonfood-producing animals or for inclusion on a
list of compounded drugs for use as antidotes for food-producing
animals or for use as sedatives or anesthetics for free-ranging
wildlife species as described in GFI #256. That Federal Register
notice describes information requested by FDA to evaluate
nominations and explains when FDA will include bulk drug substances
on a list. Such nominations will be collected in a separate docket.
---------------------------------------------------------------------------

    In addition, editorial changes were made to improve clarity in the
final guidance. The guidance announced in this notice finalizes the
draft guidance dated November 2019. However, as explained in section II
of this notice, the information collection recommendations footnoted
with an asterisk are subject to OMB review and approval and are not for
current implementation.
    This level 1 guidance is being issued consistent with FDA's good
guidance practices regulation (21 CFR 10.115). The guidance represents
the current thinking of FDA on compounding animal drugs from bulk drug
substances. It does not establish any rights for any person and is not
binding on FDA or the public. You can use an alternative approach if it
satisfies the requirements of the applicable statutes and regulations.

II. Paperwork Reduction Act of 1995

    In compliance with 44 U.S.C. 3507, FDA has submitted the following
proposed collection of information to OMB for review and clearance. FDA
is issuing this guidance as final, footnoting with an asterisk
recommendation that include information collection subject to review
and approval by OMB under the PRA. FDA will implement the information
collection recommendations if OMB approves them. At that time, FDA will
announce OMB approval in the Federal Register and update the guidance
to reflect this approval.
    Title: Compounding Animal Drugs from Bulk Drug Substances (OMB
Control Number 0910-NEW).
    Description of Respondents: The respondents to the information
collection are pharmacists in either State-licensed pharmacies or
Federal facilities, or veterinarians who compound animal drugs from
bulk drug substances.
    Description: The Center for Veterinary Medicine has developed GFI
#256 to address a need for Agency guidance in its work with the animal
health industry. The guidance describes FDA's current thinking, based
on our current understanding of the risks of animal drugs compounded
from bulk drug substances, and describes the circumstances under which
FDA generally does not intend to take enforcement action against
pharmacists and veterinarians who compound animal drugs from bulk drug
substances.
    In the Federal Register of November 20, 2019 (84 FR 64085), we
published a notice of availability announcing draft guidance GFI #256,
including an analysis under the PRA, and solicited public comment on
the proposed collection of information. Comments regarding the
information collection included concerns that the guidance document
will impose requirements not placed on other prescribers. In any other
setting, the comments suggested, the prescription itself serves as
documentation of the veterinarian's determination of clinical need. We
disagree with these comments suggesting that a prescription serves the
same purpose as the medical rationale documentation recommended in GFI
#256. The documentation of the medical rationale by the compounding
pharmacist is recommended for copies of approved products because a
prescription demonstrates an animal's need for a prescription drug but
does not explain why an approved product could not be used legally to
treat the animal. The medical rationale addresses the clinical need for
an animal drug compounded from a bulk drug substance when there is an
approved product available.
    Our exercise of discretion is dependent upon our ability to assess
whether the circumstances under which FDA intends to exercise such
discretion, as described in the guidance, exist. FDA staff may use
pharmacy and veterinary records, among other things, to determine the
circumstances surrounding the compounding activity. Except with regard
to the recommendations that compounders document rationales for
prescribing a compounded product from a bulk drug substance, routine
business records kept by pharmacists who compound animal drugs from
bulk drug substances and veterinarians who compound animal drugs from
bulk drug substances, as well as veterinarians prescribing compounded
animal drugs within a valid veterinarian-client-patient relationship,
should be adequate to demonstrate that the circumstances described in
the guidance exist. While we believe it is usual and customary business
practice for veterinarians to document medical rationales for
prescribing a compounded product as recommended in the guidance, we
acknowledge that documenting this information by the pharmacist
compounder, as well as documenting the rationale for using a bulk drug
substance as the source of the active ingredient by the veterinarian/
pharmacist compounder, may not be usual and customary practice. We have
therefore included an estimate for recordkeeping to account for burden
beyond that which may be usual and customary for respondents who follow
the recommended documentation of rationales for compounding the drug
product from bulk drug substance as discussed in the guidance.
    We estimate the burden of the information collection as follows:

                                                   Table 1--Estimated Annual Recordkeeping Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                   Number of
                                                   Number of      records per    Total annual
                   Activity                      recordkeepers   recordkeeper       records         Average burden per recordkeeping        Total hours
                                                                      \2\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Documenting rationales by licensed                       7,500           1,134       8,505,000  0.017 (1 minute)........................         144,585
 veterinarian/pharmacist compounder.
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
\2\ Rounded to the nearest whole number.

    We have revised figures from our 60-day notice to reflect a more
recent review of our experience with the information collection.
    Sections III.A.5 and III.A.6 of the guidance describe circumstances
under which FDA recommends veterinarian and pharmacist compounders
document the prescribing veterinarian's medical rationale and the
reason that a bulk drug substance is being used as the source of the
active ingredient. Based on our evaluation, we believe it is usual and
customary business practice for veterinarians to document the medical
rationale, as recommended in the guidance. However, we believe
pharmacist compounders may not document the information recommended in
the guidance as a usual and customary business practice. According to
the American Pharmacists Association, of the approximately 56,000
community-based pharmacies in the United States, about 7,500 pharmacies
specialize in compounding services.\2\ We assume 11,339,400
prescriptions will be written for compounded animal drugs annually.
Based on our experience with the regulation of compounded animal drugs,
we assume 50 to 75 percent of these prescriptions will result in
documenting rationales as discussed in the guidance. Using the upper-
bound estimate of 75 percent, approximately 8,504,550 prescriptions
(0.75 x

11,339,400 prescriptions) will necessitate documenting rationales.
Averaging this figure equally among 7,500 compounding pharmacies, 1,134
(rounded to the nearest whole number) rationales will be documented
annually, for a total of 8,505,000 records. We estimate it will take 1
minute (0.017 hours) to document the rationales described in the
guidance, for a total of 144,585 hours, as reported in table 1.
---------------------------------------------------------------------------

    \2\ American Pharmacists Association, ``Frequently Asked
Questions About Pharmaceutical Compounding,'' n.d., https://www.pharmacist.com/Practice/Patient-Care-Services/Compounding/Compounding-FAQs (accessed September 15, 2021). We currently have no
data on the number of veterinarians who compound drugs for
individual patients, specifically, compound drugs from bulk drug
substances for individual patients; therefore, we are including this
class of respondents in our burden estimate.
---------------------------------------------------------------------------

    Under 5 CFR 1320.3(b)(2), the time, effort, and financial resources
necessary to comply with a collection of information are excluded from
the burden estimate if the reporting, recordkeeping, or disclosure
activities needed to comply are usual and customary because they would
occur in the normal course of activities. If the compounded drug is
compounded for use as an antidote for food-producing animals or for use
as a sedative or anesthetic for free-ranging wildlife species, section
III.C.3 of the guidance recommends that the veterinarian establishes
and documents a scientifically based withdrawal time that ensures
residues of the: (1) Antidote and the underlying toxin or (2) sedative
or anesthetic are not present in the animal at the time of slaughter or
harvest or the veterinarian ensures the animal does not enter the food
supply. We believe that it is usual and customary for veterinarians to
establish and document a scientifically based withdrawal time as a
matter of maintaining an adequate medical record in routine practice
and, therefore, estimate no burden for the time it would take for a
veterinarian to make this record. See 5 CFR 1320.3(b)(2).
    In addition, the guidance makes a number of recommendations
regarding the labeling of animal drugs compounded from bulk drug
substances. In sections III.A.8, III.B.6, and III.C.6, the guidance
recommends basic information that pharmacists and veterinarians should
include on the label of the compounded drug, such as the name and
strength of the drug and the name, address, and contact information for
the compounding pharmacy or compounding veterinarian. We believe that
it is usual and customary for pharmacists and veterinarians to include
such information on the labels of compounded animal drugs in the normal
course of their activities, and therefore, estimate no burden for the
time it would take to prepare such labeling. See 5 CFR 1320.3(b)(2).
Sections III.A.8, III.B.6, and III.C.6 of the guidance also recommend
compounders (pharmacists and veterinarians) include several specific
statements on the label of animal drugs compounded from bulk drug
substances (e.g., ``This is a compounded drug. Not an FDA approved or
indexed drug.''). Because these recommended labeling statements are
public disclosure of information originally supplied by the Federal
Government to the recipient for the purpose of disclosure to the public
(5 CFR 1320.3(c)(2)), they are exempt from OMB review and approval
under the PRA.

III. Electronic Access

    Persons with access to the internet may obtain the guidance at
https://www.fda.gov/animal-veterinary/guidance-regulations/guidance-industry, https://www.fda.gov/regulatory-information/search-fda-guidance-documents, or https://www.regulations.gov.

    Dated: April 11, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022-08092 Filed 4-13-22; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register: June 1, 2010 (Volume 75, Number 104)]
[Notices]
[Page 30389-30390]
[DOCID:fr01jn10-60]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 13727-000]

City of Santa Fe, NM; Notice of Application Accepted for Filing
and Soliciting Comments, Motions To Intervene, Protests,
Recommendations, and Terms and Conditions

May 24, 2010.
    Take notice that the following hydroelectric application has been
filed with the Commission and is available for public inspection:
    a. Type of Application: Conduit Exemption.
    b. Project No.: 13727-000.
    c. Date filed: May 10, 2010.
    d. Applicant: City of Santa Fe, New Mexico.
    e. Name of Project: Santa Fe Canyon Hydroelectric Project.
    f. Location: The proposed Santa Fe Canyon Hydroelectric Project
would be located on a pipeline in the City of Santa Fe's water
distribution system located in Santa Fe County, New Mexico. The land on
which all the project structures are located is owned by the applicant.
    g. Filed Pursuant to: Federal Power Act 16 U.S.C. 791a-825r.
    h. Applicant Contact: Mr. Dale Lyons, Water Resources Coordinator,
City of Santa Fe Water Division, 801 West San Mateo Road, Santa Fe, New
Mexico 87505; telephone<PHONE_NUMBER>.
    i. FERC Contact: Linda Stewart, telephone<PHONE_NUMBER>, and e-
mail address<EMAIL_ADDRESS>    j. Status of Environmental Analysis: This application is ready for
environmental analysis at this time, and the Commission is requesting
comments, reply comments, recommendations, terms and conditions, and
prescriptions.
    k. Deadline for filing responsive documents: Due to the small size
and location of the proposed project in a closed system, as well as the
resource agency consultation letters filed with the application, the
60-day timeframe specified in 18 CFR 4.43(b) for filing all comments,
motions to intervene, protests, recommendations, terms and conditions,
and prescriptions is shortened to 30 days from the issuance date of
this notice. All reply comments filed in response to comments submitted
by any resource agency, Indian tribe, or person, must be filed with the
Commission within 45 days from the issuance date of this notice.
    Comments, protests, and interventions may be filed electronically
via the Internet in lieu of paper; see 18 CFR 385.2001(a)(1)(iii) and
the instructions on the Commission's Web site under the ``e-Filing''
link. The Commission strongly encourages electronic filings.
    The Commission's Rules of Practice and Procedure require all
intervenors filing documents with the Commission to serve a copy of
that document on each person in the official service list for the
project. Further, if an intervenor files comments or documents with the
Commission relating to the merits of an issue that may affect the
responsibilities of a particular resource agency, they must also serve
a copy of the document on that resource agency.
    l. Description of Project: The proposed Santa Fe Canyon
Hydroelectric Project would consist of: (1) A proposed new concrete
vault containing one turbine generating unit having an installed
capacity of 90 kilowatts; and (2) appurtenant facilities. The project
would have an estimated annual generation of 394,900 kilowatt-hours
that would be sold to a local utility.
    m. This filing is available for review and reproduction at the
Commission in the Public Reference Room, Room 2A, 888 First Street,
NE., Washington, DC 20426. The filing may also be viewed on the Web at
http://www.ferc.gov using the ``eLibrary'' link. Enter the docket
number, here P-13727, in the docket number field to access the
document. For assistance, call toll-free 1-866-208-3676 or e-mail
<EMAIL_ADDRESS>For TTY, call<PHONE_NUMBER>. A copy is
also available for review and reproduction at the address in item h
above.
    n. Development Application--Any qualified applicant desiring to
file a competing application must submit to the Commission, on or
before the specified deadline date for the particular application, a
competing development application, or a notice of intent to file such
an application. Submission of a timely notice of intent allows an
interested person to file the competing development application no
later than 120 days after the specified deadline date for the
particular application. Applications for preliminary permits will not
be accepted in response to this notice.
    o. Notice of Intent--A notice of intent must specify the exact
name, business address, and telephone number of the prospective
applicant, and must include an unequivocal statement of intent to
submit a competing development application. A notice of intent must be
served on the applicant(s) named in this public notice.
    p. Protests or Motions to Intervene--Anyone may submit a protest or
a motion to intervene in accordance with the requirements of Rules of
Practice and Procedure, 18 CFR 385.210, 385.211, and 385.214. In
determining the appropriate action to take, the Commission will
consider all protests filed, but only those who file a motion to
intervene in accordance with the Commission's Rules may become a party
to the proceeding. Any protests or motions to intervene must be
received on or before the specified deadline date for the particular
application.
    q. All filings must (1) Bear in all capital letters the title
``PROTEST'', ``MOTION TO INTERVENE'', ``NOTICE OF INTENT TO FILE
COMPETING APPLICATION'', ``COMPETING APPLICATION'', ``COMMENTS'',
``REPLY COMMENTS,'' ``RECOMMENDATIONS,'' ``TERMS AND CONDITIONS,'' or
``PRESCRIPTIONS;'' (2) set forth in the heading the name of the
applicant and the project number of the application to which the filing
responds; (3) furnish the name, address, and telephone number of the
person protesting or intervening; and (4) otherwise comply with the
requirements of 18 CFR 385.2001 through 385.2005. All comments,
recommendations, terms and conditions or prescriptions must set forth
their evidentiary basis and otherwise comply with the requirements of
18 CFR 4.34(b). Agencies may obtain copies of the application directly
from the applicant. Any of these documents must be filed by providing
the original and eight copies to: The Secretary, Federal Energy
Regulatory Commission, 888 First Street, NE., Washington, DC 20426. An
additional copy must be sent to Director, Division of Hydropower
Administration and Compliance, Office of Energy Projects, Federal
Energy Regulatory Commission, at the above address. A copy of any
protest or motion to intervene must be served upon each representative
of the applicant specified in the particular application. A copy of all
other filings in reference to this application must be accompanied by
proof of service on all persons listed in the service list prepared by
the Commission in this proceeding, in accordance with 18 CFR 4.34(b)
and 385.2010.

    r. Waiver of Pre-filing Consultation: On February 2, 2010, the
applicant requested the agencies' support to waive the Commission's
consultation requirements under 18 CFR 4.38(c), noting that it had
already met with the U.S. Department of the Interior's Fish and
Wildlife Service (FWS) and New Mexico Department of Game and Fish
(NMDGF) . The FWS concurred with the applicant's request on January 7,
2010, and the NMDGF concurred with the request on January 25, 2010. No
other comments were received. Therefore, we intend to accept the
consultation that has occurred on this project during the pre-filing
period and we intend to waive pre-filing consultation under section
4.38(c), which requires, among other things, conducting studies
requested by resource agencies, and distributing and consulting on a
draft exemption application.

Kimberly D. Bose,
Secretary.
[FR Doc. 2010-12993 Filed 5-28-10; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 86, Number 185 (Tuesday, September 28, 2021)]
[Notices]
[Page 53656]
[FR Doc No: 2021-20994]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[FRL-9065-01-OW]

Notice of Virtual Public Meeting of the Environmental Financial
Advisory Board via Webcast

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice of virtual public meeting.

-----------------------------------------------------------------------

SUMMARY: The United States Environmental Protection Agency (EPA)
announces a virtual public meeting via webcast of the Environmental
Financial Advisory Board (EFAB). The meeting will be shared in real-
time via webcast and public comments may be provided in writing in
advance or virtually via webcast. Please see SUPPLEMENTARY INFORMATION
for further details. The purpose of the meeting will be for the EFAB to
provide workgroup updates and work products for previously accepted and
potential charges, receive updates on EPA activities relating to
administration priorities and environmental finance, and consider
possible future advisory topics.

DATES: The virtual public meeting will be held on October 13, 2021 from
12 p.m. to 4 p.m. Eastern Time.

ADDRESSES: Information to access the webcast will be provided upon
registration in advance of the meeting.

FOR FURTHER INFORMATION CONTACT: Any member of the public who wants
information about the meeting may contact Ed Chu, the EFAB Designated
Federal Officer, via telephone/voicemail at<PHONE_NUMBER> or email to
<EMAIL_ADDRESS>General information concerning the EFAB is available at
https://www.epa.gov/waterfinancecenter/efab.

SUPPLEMENTARY INFORMATION:
    Background: The EFAB is an EPA advisory committee chartered under
the Federal Advisory Committee Act (FACA), 5 U.S.C. App. 2, to provide
advice and recommendations to EPA on innovative approaches to funding
environmental programs, projects, and activities. Administrative
support for the EFAB is provided by the Water Infrastructure and
Resiliency Finance Center within EPA's Office of Water. Pursuant to
FACA and EPA policy, notice is hereby given that the EFAB will hold a
virtual public meeting via webcast for the following purposes:
    (1) Provide EFAB workgroup updates to the Board regarding work
products related to the Opportunity Zones charge the Board accepted
during its October 2020 meeting;
    (2) Discuss potential future EFAB charges including Stormwater
Credit Trading, Environmental Risk and Cost of Capital, Financing Small
Manufacturer Pollution Prevention Projects, and others; and
    (3) Receive briefings from invited EPA speakers on environmental
finance topics.
    Registration for the Meeting: To register for the meeting, please
visit https://www.epa.gov/waterfinancecenter/efab#meeting. Interested
persons who wish to attend the meeting via webcast must register by
October 5, 2021. Pre-registration is strongly encouraged.
    Availability of Meeting Materials: Meeting materials, including the
meeting agenda and briefing materials, will be available on EPA's
website at https://www.epa.gov/waterfinancecenter/efab.
    Procedures for Providing Public Input: Public comment for
consideration by EPA's federal advisory committees has a different
purpose from public comment provided to EPA program offices. Therefore,
the process for submitting comments to a federal advisory committee is
different from the process used to submit comments to an EPA program
office. Federal advisory committees provide independent advice to EPA.
Members of the public may submit comments on matters being considered
by the EFAB for consideration as the Board develops its advice and
recommendations to EPA.
    Oral Statements: In general, individuals or groups requesting an
oral presentation at a virtual public meeting will be limited to three
minutes each. Persons interested in providing oral statements at the
October 2021 meeting virtually via webcast should register in advance
and provide notification, as noted in the registration confirmation, by
October 5, 2021 to be placed on the list of registered speakers.
    Written Statements: Written statements for the October 2021 meeting
should be received by October 5, 2021 so that the information can be
made available to the EFAB for its consideration prior to the meeting.
Written statements should be sent via email to<EMAIL_ADDRESS>Members of
the public should be aware that their personal contact information, if
included in any written comments, may be posted to the EFAB website.
Copyrighted material will not be posted without explicit permission of
the copyright holder.
    Accessibility: For information on access or services for
individuals with disabilities or to request accommodations for a
disability, please register for the meeting and list any special
requirements or accommodations needed on the registration form at least
10 business days prior to the meeting to allow as much time as possible
to process your request.

    Dated: September 22, 2021.
Andrew D. Sawyers,
Director, Office of Wastewater Management, Office of Water.
[FR Doc. 2021-20994 Filed 9-27-21; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 82, Number 103 (Wednesday, May 31, 2017)]
[Notices]
[Pages 25022-25023]
[FR Doc No: 2017-11147]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-80758; File No. SR-PEARL-2017-24]

Self-Regulatory Organizations; MIAX PEARL, LLC; Notice of Filing
and Immediate Effectiveness of a Proposed Rule Change To Amend MIAX
PEARL Rule 510 To Extend the Penny Pilot Program

May 24, 2017.
    Pursuant to the provisions of Section 19(b)(1) of the Securities
Exchange Act of 1934 (``Act'') \1\ and Rule 19b-4 thereunder,\2\ notice
is hereby given that on May 16, 2017, MIAX PEARL, LLC (``MIAX PEARL''
or ``Exchange'') filed with the Securities and Exchange Commission
(``Commission'') a proposed rule change as described in Items I, II,
and III below, which Items have been prepared by the Exchange. The
Commission is publishing this notice to solicit comments on the
proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange is filing a proposal to amend Exchange Rule 510,
Interpretations and Policies .01, to extend the pilot program for the
quoting and trading of certain options in pennies.
    The text of the proposed rule change is available on the Exchange's
Web site at http://www.miaxoptions.com/rule-filings/pearl at MIAX
PEARL's principal office, and at the Commission's Public Reference
Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the Exchange included statements
concerning the purpose of and basis for the proposed rule change and
discussed any comments it received on the proposed rule change. The
text of these statements may be examined at the places specified in
Item IV below. The Exchange has prepared summaries, set forth in
sections A, B, and C below, of the most significant aspects of such
statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The Exchange is a participant in an industry-wide pilot program
that provides for the quoting and trading of certain option classes in
penny increments (the ``Penny Pilot Program'' or ``Program''). The
Penny Pilot Program allows the quoting and trading of certain option
classes in minimum increments of $0.01 for all series in such option
classes with a price of less than $3.00; and in minimum increments of
$0.05 for all series in such option classes with a price of $3.00 or
higher. Options overlying the PowerShares QQQTM (``QQQ''),
SPDR[supreg] S&P 500[supreg] ETF (``SPY''), and iShares[supreg] Russell
2000 ETF (``IWM''), however, are quoted and traded in minimum
increments of $0.01 for all series regardless of the price. The Penny
Pilot Program was initiated at the then existing option exchanges in
January 2007 \3\ and currently includes more than 300 of the most
active option classes. The Penny Pilot Program is currently scheduled
to expire on June 30, 2017.\4\ The purpose of the proposed rule change
is to extend the Penny Pilot Program in its current format through
December 31, 2017.
---------------------------------------------------------------------------

    \3\ See Securities Exchange Act Release Nos. 55154 (January 23,
2007), 72 FR 4743 (February 1, 2007) (SR-CBOE-2006-92); 55161
(January 24, 2007), 72 FR 4754 (February 1, 2007) (SR-ISE-2006-62);
54886 (December 6, 2006), 71 FR 74979 (December 13, 2006) (SR-Phlx-
2006-74); 54590 (October 12, 2006), 71 FR 61525 (October 18, 2006)
(SR-NYSEArca-2006-73); and 54741 (November 9, 2006), 71 FR 67176
(November 20, 2006) (SR-Amex-2006-106).
    \4\ See Securities Exchange Act Release No. 79778 (January 12,
2017), 82 FR 6662 (January 19, 2017) (SR-PEARL-2016-01) (extending
the Penny Pilot Program to June 30, 2017).
---------------------------------------------------------------------------

    In addition to the extension of the Penny Pilot Program through
December 31, 2017, the Exchange proposes to extend one other date in
the Rule. Currently, Interpretations and Policies .01 states that the
Exchange will replace any Penny Pilot issues that have been delisted
with the next most actively traded multiply listed option classes that
are not yet included in the Penny Pilot Program, and that the
replacement issues will be selected based on trading activity in the
previous six months. Such option classes will be added to the Penny
Pilot Program on the second trading day following January 1, 2017.\5\
Because this date has expired and the Exchange intends to continue this
practice for the duration of the Penny Pilot Program, the Exchange is
proposing to amend the Rule to reflect that such option classes will be
added to the Penny Pilot Program on the second trading day following
July 1, 2017.
---------------------------------------------------------------------------

    \5\ The month immediately preceding a replacement class's
addition to the Pilot Program i.e., June) is not used for purposes
of the six-month analysis. For example, a replacement added on the
second trading day following July 1, 2017, will be identified based
on trading activity from December 1, 2016, through May 31, 2017.
---------------------------------------------------------------------------

    The purpose of this provision is to reflect the new date on which
replacement issues may be added to the Penny Pilot Program.
2. Statutory Basis
    MIAX PEARL believes that its proposed rule change is consistent
with Section 6(b) of the Act \6\ in general, and furthers the
objectives of Section 6(b)(5)

of the Act \7\ in particular, in that it is designed to prevent
fraudulent and manipulative acts and practices, to promote just and
equitable principles of trade, to foster cooperation and coordination
with persons engaged in facilitating transactions in securities, to
remove impediments to and perfect the mechanisms of a free and open
market and a national market system and, in general, to protect
investors and the public interest.
---------------------------------------------------------------------------

    \6\ 15 U.S.C. 78f(b).
    \7\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

    In particular, the proposed rule change, which extends the Penny
Pilot Program for six months, allows the Exchange to continue to
participate in a program that has been viewed as beneficial to traders,
investors and public customers and viewed as successful by the other
options exchanges participating in it.

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule change will
impose any burden on competition that is not necessary or appropriate
in furtherance of the purposes of the Act. Specifically, the Exchange
believes that, by extending the expiration of the Pilot Program, the
proposed rule change will allow for further analysis of the Penny Pilot
Program and a determination of how the Program should be structured in
the future. In doing so, the proposed rule change will also serve to
promote regulatory clarity and consistency, thereby reducing burdens on
the marketplace, facilitating investor protection, and fostering a
competitive environment. In addition, consistent with previous
practices, the Exchange believes the other options exchanges will be
filing similar extensions of the Penny Pilot Program.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    Written comments were neither solicited nor received.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    Because the foregoing proposed rule change does not: (i)
Significantly affect the protection of investors or the public
interest; (ii) impose any significant burden on competition; and (iii)
become operative for 30 days after the date of the filing, or such
shorter time as the Commission may designate, it has become effective
pursuant to 19(b)(3)(A) of the Act \8\ and Rule 19b-4(f)(6) \9\
thereunder.
---------------------------------------------------------------------------

    \8\ 15 U.S.C. 78s(b)(3)(A).
    \9\ 17 CFR 240.19b-4(f)(6). In addition, Rule 19b-4(f)(6)
requires a self-regulatory organization to give the Commission
written notice of its intent to file the proposed rule change at
least five business days prior to the date of filing of the proposed
rule change, or such shorter time as designated by the Commission.
The Exchange has satisfied this requirement.
---------------------------------------------------------------------------

    At any time within 60 days of the filing of the proposed rule
change, the Commission summarily may temporarily suspend such rule
change if it appears to the Commission that such action is necessary or
appropriate in the public interest, for the protection of investors, or
otherwise in furtherance of the purposes of the Act. If the Commission
takes such action, the Commission shall institute proceedings to
determine whether the proposed rule should be approved or disapproved.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml); or
     Send an email to<EMAIL_ADDRESS>Please include
File Number SR-PEARL-2017-24 on the subject line.

Paper Comments

     Send paper comments in triplicate to Secretary, Securities
and Exchange Commission, 100 F Street NE., Washington, DC 20549-1090.

All submissions should refer to File Number SR-PEARL-2017-24. This file
number should be included on the subject line if email is used. To help
the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml).
    Copies of the submission, all subsequent amendments, all written
statements with respect to the proposed rule change that are filed with
the Commission, and all written communications relating to the proposed
rule change between the Commission and any person, other than those
that may be withheld from the public in accordance with the provisions
of 5 U.S.C. 552, will be available for Web site viewing and printing in
the Commission's Public Reference Room, 100 F Street NE., Washington,
DC 20549, on official business days between the hours of 10:00 a.m. and
3:00 p.m. Copies of the filing also will be available for inspection
and copying at the principal office of the Exchange. All comments
received will be posted without change; the Commission does not edit
personal identifying information from submissions. You should submit
only information that you wish to make available publicly.
    All submissions should refer to File Number SR-PEARL-2017-24 and
should be submitted on or before June 21, 2017. For the Commission, by
the Division of Trading and Markets, pursuant to delegated
authority.\10\
---------------------------------------------------------------------------

    \10\ 17 CFR 200.30-3(a)(12).

Eduardo A. Aleman,
Assistant Secretary.
[FR Doc. 2017-11147 Filed 5-30-17; 8:45 am]
 BILLING CODE 8011-01-P


[Federal Register Volume 77, Number 34 (Tuesday, February 21, 2012)]
[Proposed Rules]
[Pages 9882-9883]
[FR Doc No: 2012-3912]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Parts 141 and 142

[FRL-9635-1]

Arsenic Small Systems Compliance and Alternative Affordability
Criteria Working Group; public meeting

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: EPA is holding an initial meeting of the Arsenic Small Systems
Working Group to provide input and recommendations on barriers to the
use of point-of-use and point-of-entry treatment units, package plant,
and modular units, as well as alternative affordability criteria that
give extra weight to small, rural, and lower income communities. This
meeting will be held via Webcast and the public may attend this
meeting.

DATES: The Work Group meeting will be held on March 2, 2012 (1 p.m. to
4 p.m., Eastern Time (ET)). Persons wishing to participate must
register in advance as described in the SUPPLEMENTARY INFORMATION
section.

ADDRESSES: The meeting will be held via the Internet using a Webcast
and teleconference. Registrants will receive an Internet access link
and dial in number upon registration for the Webcast. To participate in
the Webcast, you must register in advance at the following Web address:
https://www3.gotomeeting.com/register/679236510.

FOR FURTHER INFORMATION CONTACT: For questions about this specific
meeting, contact Russ Perkinson, Office of Ground Water and Drinking
Water, U.S. Environmental Protection Agency; telephone<PHONE_NUMBER>
or by email to<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: Congressional language contained in the
Conference Report (H.R. 2055) accompanying the Consolidated
Appropriations Act of 2012 directs the Environmental Protection Agency
to convene an Arsenic Small Systems Working Group composed of
representatives from States, small publicly owned water systems, local
public health officials, drinking water consumers and treatment
manufacturers to provide input and recommendations on barriers to the
use of point-of-use and point-of-entry treatment units, package plant,
and modular units, as well as alternative affordability criteria that
give extra weight to small, rural, and lower income communities. Based
upon input from the work group, the EPA will submit to Congress a
report on actions to make alternative compliance methods more
accessible to water systems and a report on alternative affordability
criteria.
    To participate in the Webcast, you must register in advance at the
following Web address: https://www3.gotomeeting.com/register/679236510.
The number of connections available for the Webcast is limited and will
be available on a first come, first served basis. During the Webcast, a
public comment period will be held for persons wishing to participate
that have registered in advance to speak. Individual comments should be
limited to no more than three minutes and it is preferred that only one
person present the statement on behalf of a group or organization.
Individuals wishing to speak during the public comment period or
individuals without Internet access seeking alternative means to
participate in the meeting must contact Russ Perkinson at (202) 564-
4901 or by email to<EMAIL_ADDRESS>no later than February 28,
2012.

Special Accommodations

    To request special accommodations for individuals with
disabilities, please contact Russ Perkinson at<PHONE_NUMBER> or by
email to<EMAIL_ADDRESS>Please allow at least five business
days prior to the meeting to allow time to process your request.

    Dated: February 15, 2012.
Cynthia C. Dougherty,
Director, Office of Ground Water and Drinking Water.
[FR Doc. 2012-3912 Filed 2-17-12; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 77, Number 170 (Friday, August 31, 2012)]
[Notices]
[Pages 53193-53194]
[FR Doc No: 2012-21517]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings 1

    Take notice that the Commission received the following electric
corporate filings:

    Docket Numbers: EC12-136-000.
    Applicants: PacifiCorp.
    Description: Application of PacifiCorp for Approval of Acquisition
of Jurisdictional Assets from Brigham City Corporation.
    Filed Date: 8/22/12.
    Accession Number: 20120822-5125.
    Comments Due: 5 p.m. ET 9/12/12.

    Take notice that the Commission received the following electric
rate filings:

    Docket Numbers: ER10-3069-003; ER10-3070-003.
    Applicants: Alcoa Power Generating, Inc., Alcoa Power Marketing
LLC.
    Description: Alcoa Power Generating Inc., et al. submits supplement
to Updated Market Power Analysis.
    Filed Date: 8/23/12.
    Accession Number: 20120823-5025.
    Comments Due: 5 p.m. ET 9/13/12.

    Docket Numbers: ER11-4267-001; ER11-4270-001; ER11-4269-001; ER11-
4268-001; ER11-113-001.
    Applicants: Algonquin Northern Maine Gen Co., Algonquin Tinker Gen
Co., Algonquin Energy Services Inc., Granite State Electric Company,
Sandy Ridge Wind, LLC, Algonquin Windsor Locks LLC.
    Description: Algonquin Energy Services Inc., et al. submits
supplement to Notice of Change in Status.
    Filed Date: 8/22/12.
    Accession Number: 20120822-5130.
    Comments Due: 5 p.m. ET 9/12/12.

    Docket Numbers: ER12-1266-003.

    Applicants: Midwest Independent Transmission System Operator, Inc.
    Description: 8-20-12 745 Compliance to be effective 6/12/2012.
    Filed Date: 8/21/12.
    Accession Number: 20120821-5137.
    Comments Due: 5 p.m. ET 9/11/12.

    Docket Numbers: ER12-1457-003.
    Applicants: Southern California Edison Company.
    Description: GIA and Service Agreement with San Gorgonio Farms,
Inc. to be effective 3/23/2012.
    Filed Date: 8/23/12.
    Accession Number: 20120823-5000.
    Comments Due: 5 p.m. ET 9/13/12.

    Docket Numbers: ER12-2502-000.
    Applicants: PacifiCorp.
    Description: Deseret ARTSOA Rev 5 to be effective 10/22/2012.
    Filed Date: 8/22/12.
    Accession Number: 20120822-5062.
    Comments Due: 5 p.m. ET 9/12/12.

    Docket Numbers: ER12-2503-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Queue No. X2-076; Second Revised Service Agreement
Nos. 3154 and 3155 to be effective 7/23/2012.
    Filed Date: 8/22/12.
    Accession Number: 20120822-5102.
    Comments Due: 5 p.m. ET 9/12/12.

    Docket Numbers: ER12-2504-000.
    Applicants: Westar Energy, Inc.
    Description: Notice of Cancellation of certain designated Rate
Schedules to be effective 6/15/2011.
    Filed Date: 8/21/12.
    Accession Number: 20120821-5136.
    Comments Due: 5 p.m. ET 9/11/12.

    The filings are accessible in the Commission's eLibrary system by
clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: August 23, 2012.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2012-21517 Filed 8-30-12; 8:45 am]
BILLING CODE 6717-01-P